Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4-5 chronic kidney disease: a systematic review and meta-analysis

Publication Type:

Journal Article

Source:

Virol J, Volume 16, Issue 1, p.34 (2019)
Top